These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3715434)

  • 1. [Drug therapy in liver diseases: problems in intensive care].
    Follath F
    Schweiz Med Wochenschr; 1986 Apr; 116(17):549-52. PubMed ID: 3715434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug metabolism in patients with liver disease.
    Secor JW; Schenker S
    Adv Intern Med; 1987; 32():379-405. PubMed ID: 3548257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy in liver diseases].
    Zilly W
    Med Klin; 1979 Oct; 74(43):1575-80. PubMed ID: 44540
    [No Abstract]   [Full Text] [Related]  

  • 5. The disposition and effects of sedatives and analgesics in liver disease.
    Hoyampa AM; Branch RA; Schenker S
    Annu Rev Med; 1978; 29():205-18. PubMed ID: 348033
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for drug therapy in renal failure.
    Bennett WM; Singer I; Golper T; Feig P; Coggins CJ
    Ann Intern Med; 1977 Jun; 86(6):754-83. PubMed ID: 869359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of liver diseases on drug disposition.
    Roberts RK; Branch RA; Desmond PV; Schenker S
    Clin Gastroenterol; 1979 Jan; 8(1):105-21. PubMed ID: 369741
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and professional reference guides. Critical values for therapeutic drug levels.
    Millar S
    MLO Med Lab Obs; 2001 Aug; 33(8 Suppl):15. PubMed ID: 11571829
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug kinetics and artificial kidneys.
    Gibson TB; Nelson HA
    Clin Pharmacokinet; 1977; 2(6):403-26. PubMed ID: 22417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transplacental passage of drugs].
    Sjöqvist F
    Nord Med; 1967 Oct; 78(42):1354-8. PubMed ID: 4385511
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of ethanol on drug and metabolite pharmacokinetics.
    Lane EA; Guthrie S; Linnoila M
    Clin Pharmacokinet; 1985; 10(3):228-47. PubMed ID: 2861929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of pharmacokinetic drug interactions. 4: Mechanisms of interaction during biotransformation].
    Box A; Heydel E; Fürtig W
    Pharmazie; 1984 Apr; 39(4):282-92. PubMed ID: 6377334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of hepato-biliary diseases on drug metabolism (author's transl)].
    Pessayre D; Allemand H; Benhamou JP
    Nouv Presse Med; 1977 Oct; 6(35):3209-19. PubMed ID: 928049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of age on drug metabolism. Implications for drug dosage.
    Triggs EJ; Hooper WD; Dickinson RG
    Med J Aust; 1984 Dec 8-22; 141(12-13):823-7. PubMed ID: 6390104
    [No Abstract]   [Full Text] [Related]  

  • 15. The Impact of Liver and Renal Dysfunction on the Pharmacokinetics and Pharmacodynamics of Sedative and Analgesic Drugs in Critically Ill Adult Patients.
    Yogaratnam D; Ditch K; Medeiros K; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2016 Jun; 28(2):183-94. PubMed ID: 27215356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical problems in the application of sedatives in patients with chronic liver disease (author's transl)].
    Becker K
    Z Gastroenterol; 1977 Jun; 15(6):356-61. PubMed ID: 888484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug monitoring in intensive care].
    Gugler R; Ochs HR
    Verh Dtsch Ges Herz Kreislaufforsch; 1983; 49():93-7. PubMed ID: 6666313
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug prescribing in hepatobiliary disease.
    Roberts RK; Desmond PV; Schenker S
    Drugs; 1979 Mar; 17(3):198-212. PubMed ID: 378647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum drug concentrations in clinical perspective.
    Koch-Weser J
    Ther Drug Monit; 1981; 3(1):3-16. PubMed ID: 7015580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring.
    Bayer WH
    West J Med; 1986 Oct; 145(4):524-7. PubMed ID: 3538663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.